These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2127844)

  • 1. [A clinico-pathogenetic assessment of the membrane structure and functions of the peripheral blood lymphocytes in insulin-dependent diabetes mellitus].
    Nelaeva AA; Kashuba EA; Kardakov IuI
    Probl Endokrinol (Mosk); 1990; 36(5):24-8. PubMed ID: 2127844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The indices of the lipid peroxidation and desaturation of the blood serum in diabetes mellitus in children].
    Turkina TI; Marchenko LF; Zezerov AE; Pozniak TI; Martynova MI; Kiseleva EV
    Probl Endokrinol (Mosk); 1991; 37(4):13-5. PubMed ID: 1788182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative aspects of the changes in lipid metabolism indicators in lymphocyte and erythrocyte membranes in children with diabetes mellitus].
    Turkina TI; Izvekova VA; Marchenko LF; Sapelkina LV
    Pediatriia; 1991; (2):30-3. PubMed ID: 2057287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association of infective hepatitis type A (HAV) and diabetes mellitus.
    Makeen AM
    Trop Geogr Med; 1992 Oct; 44(4):362-4. PubMed ID: 1295148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Lipid peroxidation in patients with hypertension and renal hypertension against a background of diabetes mellitus].
    Kuznetsov NS; Abulela AM; Kulagin IuI; Neskromnyĭ VN; Babin IuF
    Lik Sprava; 1996; (5-6):117-8. PubMed ID: 9377373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indobufen induced modification of phospholipid composition in diabetic platelets.
    Dmoszyńska A; Sokołowska B; Walter-Croneck A; Przesmycki K; Ledwozyw A
    Pol J Pharmacol; 1996; 48(3):331-4. PubMed ID: 9112672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of platelet-lymphocyte aggregation in circulating blood of patients with type 1 diabetes with and without diabetic nephropathy.
    Vitkovsky Y; Kuznik B; Solpov A; Magen E
    Isr Med Assoc J; 2008 Oct; 10(10):691-4. PubMed ID: 19009947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The results of a comparative study of the lipid peroxidation processes and of the malondialdehyde level of the blood cells in patients with diabetic angiopathies and during insulin therapy].
    Rud'ko IA; Balashova TS; Golega EN; Balabolkin MI; Kubatiev AA
    Ter Arkh; 1994; 66(10):27-9. PubMed ID: 7863440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The characteristics of lymphocyte membrane function in pyelonephritis patients].
    Maĭdannyk VH
    Lik Sprava; 1995; (3-4):85-8. PubMed ID: 8819930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of structuro-functional changes in cell membranes in the formation of the immune response in patients with chronic pyelonephritis].
    Tsvettsikh VE; Krylov VI; Lerner GN; Berdichevskiĭ BA
    Ter Arkh; 1991; 63(2):105-7. PubMed ID: 1646487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo effect of lipoic acid on lipid peroxidation in patients with diabetic neuropathy.
    Androne L; Gavan NA; Veresiu IA; Orasan R
    In Vivo; 2000; 14(2):327-30. PubMed ID: 10836205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetic ketoacidosis (causes, clinico-biochemical correlations and terminology problems)].
    Blagosklonnaia IaV; Berezko IuN; Vershinin VN; Zalevskaia AG; Kudriashova MI
    Ter Arkh; 1984; 56(10):94-7. PubMed ID: 6441297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of biosynthetic insulin on lipid peroxidation in erythrocyte membranes in patients with type I diabetes mellitus].
    Balashova TS; Golega EN; Rud'ko IA; Balabolkin MI; Kubatiev AA
    Probl Endokrinol (Mosk); 1994; 40(3):12-5. PubMed ID: 8072992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding diabetes in children.
    Malone JI
    Adv Pediatr; 1994; 41():33-52. PubMed ID: 7992688
    [No Abstract]   [Full Text] [Related]  

  • 15. High density lipoprotein changes during treatment of diabetic ketoacidosis.
    Joven J; Rubiés-Prat J; de la Figuera M; Valdés M; Villabona CM; Chacón P; Masdeu S
    Diabete Metab; 1985 Apr; 11(2):102-5. PubMed ID: 3924672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patho- and morphogenesis of diabetes mellitus and early diabetic nephropathy].
    Severgina ES; Ponomarev AB
    Arkh Patol; 1988; 50(4):80-5. PubMed ID: 3044300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phospholipid composition of normal thrombocytes and in diabetes mellitus].
    Saatov TS; Abidov AA; Isamitdinova IM
    Probl Endokrinol (Mosk); 1982; 28(5):3-6. PubMed ID: 7145882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin and glucagon ratio in the patho-physiology of diabetic ketoacidosis and hyperosmolar hyperglycemic non-ketotic diabetes.
    Wahid M; Naveed AK; Hussain I
    J Coll Physicians Surg Pak; 2006 Jan; 16(1):11-4. PubMed ID: 16441980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro secretion of interleukin 2 and expression of IL-2 receptor in peripheral blood lymphocytes in high risk of insulin-dependent diabetes mellitus subjects.
    Kretowski A; Myśliwiec J; Szelachowska M; Brzozowski C; Pietruczuk M; Kinalska I
    Arch Immunol Ther Exp (Warsz); 1999; 47(1):45-9. PubMed ID: 11729828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of K+ transport through erythrocyte membranes of the patients with insulin dependent diabetes mellitus: effect of insulin therapy].
    Kubatiev AA; Balashova TS; Balabolkin MI; Tomilova EN
    Biull Eksp Biol Med; 1996 Jul; 122(7):109-13. PubMed ID: 9303684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.